Circular RNA‐Based Molecular Computation Enhances Plasma Biomarker Detection in Biliary Tract Cancer
Abstract
Abstract Molecular diagnosis of biliary tract cancer (BTC) remains a significant clinical challenge due to the lack of sensitive and specific diagnostic tools. Although large panels based on multi‐biomarkers have demonstrated potential in enhancing diagnostic accuracy, their clinical application is hindered by complexity and high costs. To overcome these limitations, we have developed a DNA‐based molecular computation system that integrates the detection of plasma circular RNAs (circRNAs) with molecular computation, enabling intelligent and rapid diagnosis of BTC. By identifying and validating a specific and small set of circRNA biomarkers that are differentially expressed in BTC patients, we designed a DNA computation framework that directly translates biomarker levels into diagnostic outcomes without the need of external analysis and interpretation. In a validation cohort of 70 individuals, our approach achieved a diagnostic accuracy of 83%, demonstrating its potential as a cost‐effective and efficient tool for rapid diagnosis of BTC. This work highlights the potential of molecular computation in enhancing integrated and rapid cancer diagnostics, paving the way for clinical implementation.
Article Details
Authors (10)
Yunben Yang
Department of Hepato‐Pancreato‐Biliary and Gastric Medical Oncology Zhejiang Cancer Hospital Hangzhou China
Wenyi Lv
Zhejiang Cancer Hospital, Key Laboratory of Zhejiang Province for Aptamers and Theranostics Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang China
Yongfu Shao
Chunjing Xu
Department of Oncology Zhejiang Hospital Hangzhou Zhejiang China
Yawei Feng
Department of Mechanical Engineering, City University of Hong Kong
Yihui Huang
Yinye Yao
Department of Hepato‐Pancreato‐Biliary and Gastric Medical Oncology Zhejiang Cancer Hospital Hangzhou China
Jieer Ying
Ruizi Peng
The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM)
Da Han
Hangzhou Institute of Medicine